Cargando…
EPO for stroke therapy - Is there a future for further clinical development?
Autores principales: | Minnerup, Jens, Wersching, Heike, Schäbitz, Wolf-Rüdiger |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880017/ https://www.ncbi.nlm.nih.gov/pubmed/20459870 http://dx.doi.org/10.1186/2040-7378-2-10 |
Ejemplares similares
-
Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011) -
Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success
por: Minnerup, Jens, et al.
Publicado: (2014) -
Late Onset Postpartum Eclampsia: It is Really Never Too Late—A Case of Eclampsia 8 Weeks after Delivery
por: Minnerup, Jens, et al.
Publicado: (2009) -
Effects of Different Exercise Strategies and Intensities on Memory Performance and Neurogenesis
por: Diederich, Kai, et al.
Publicado: (2017) -
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies
por: Minnerup, Jens, et al.
Publicado: (2009)